Its imbalanced receptor affinity and biased signaling provide enhanced insulin secretion and improved metabolic outcomes beyond selective GLP-1 agonism
Reconstituted peptides generally have a shorter shelf life than their lyophilized counterparts because water can accelerate chemical degradation and increase the risk of contamination
Pregnancy and breastfeeding insufficient safety data
The compound requires subcutaneous administration for maximum bioavailability, as oral administration results in poor absorption due to first-pass metabolism
Safety Profile, Side Effects, and Contraindications MOTS-c has a favorable safety profile in the published research to date, which is unsurprising given that it is an endogenous peptide that naturally circulates in human blood
Side effects tend to be mild and dose-dependent -- injection site reactions, temporary water retention, and mild tingling or flushing